The fabian HFO is now able to collect ventilation and oxygenation patient data in 1 device instead of 2, by connecting the pulse oximetry sensor via USB to the ventilator.
This combined technology platform aims to optimize patient assessments and improve workflow, allowing clinicians to spend more valuable time tending to patients, according to the press release.
“The synergies realized between our companies and products support Masimo’s mission to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications," Masimo’s president of worldwide OEM business & corporate development Rick Fishel said in prepared remarks. "We are very pleased that Masimo’s SET pulse oximetry platform is a key component in Acutronic’s new neonatal ventilators."
Irvine, Calif.-based Masimo beat Wall Street’s expectations in the 3rd quarter. Masimo reported profits of $15.6 million, or 27¢ per share, on sales of $131.4 million for the 3 months ended Sept. 28. Analysts on Wall Street were looking for earnings per share of 26¢.